Market PotentialThe additional safety from the abuse-deterrent technology could potentially grow the market and drive upward revisions to estimates.
PartnershipNutriband has a partnership with Kindeva Drug Delivery to add the AVERSA technology to Kindeva’s transdermal fentanyl patch, potentially stopping misuse effectively.
Product DevelopmentThe AVERSA Fentanyl patch could prevent abuse and accidental misuse of fentanyl transdermal patches, potentially allowing for decreased restrictions and improved access for patients with severe chronic pain.